We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
-0.82%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$1.61B
AUM Growth
+$447M
Cap. Flow
+$533M
Cap. Flow %
33.15%
Top 10 Hldgs %
11.86%
Holding
2,259
New
642
Increased
549
Reduced
466
Closed
595

Top Sells

Rank Stock Value
1
EOG icon
EOG Resources
EOG
+$4.13M
2
NVDA icon
NVIDIA
NVDA
+$4.12M
3
PFE icon
Pfizer
PFE
+$4.01M
4
LNG icon
Cheniere Energy
LNG
+$3.83M
5
HOLX
Hologic
HOLX
+$3.1M

Sector Composition

Rank Sector Weight
1 Financials 13.44%
2 Technology 13.16%
3 Healthcare 12.56%
4 Industrials 12.44%
5 Consumer Discretionary 10.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLG icon
2126
SL Green Realty
SLG
$3.88B
-19,142
Closed -$878K
SLGN icon
2127
Silgan Holdings
SLGN
$4.91B
-5,314
Closed -$215K
SLP icon
2128
Simulations Plus
SLP
$371M
-62,322
Closed -$1.14M
SM icon
2129
SM Energy
SM
$7.96B
-20,894
Closed -$391K
SMPL icon
2130
Simply Good Foods
SMPL
$904M
-62,906
Closed -$1.26M
SN icon
2131
SharkNinja
SN
$21B
-3,962
Closed -$443K
SNDA icon
2132
Sonida Senior Living
SNDA
$1.97B
-7,143
Closed -$233K
SNV
2133
DELISTED
Synovus
SNV
-11,653
Closed -$583K
SNY icon
2134
Sanofi
SNY
$104B
-4,222
Closed -$205K
SOPH icon
2135
SOPHiA GENETICS
SOPH
$480M
-24,967
Closed -$117K
SRCE icon
2136
1st Source
SRCE
$2.07B
-7,125
Closed -$445K
SSRM icon
2137
SSR Mining
SSRM
$5.57B
-14,827
Closed -$325K
STNE icon
2138
StoneCo
STNE
$2.62B
-38,730
Closed -$573K
STOK icon
2139
Stoke Therapeutics
STOK
$1.82B
-7,076
Closed -$225K
STZ icon
2140
Constellation Brands
STZ
$22.2B
-2,366
Closed -$326K
SWKS icon
2141
Skyworks Solutions
SWKS
$9.06B
-13,866
Closed -$879K
T icon
2142
AT&T
T
$165B
-19,249
Closed -$478K
TALK icon
2143
Talkspace
TALK
$873M
-96,540
Closed -$350K
TARA icon
2144
Protara Therapeutics
TARA
$226M
-52,332
Closed -$279K
TASK icon
2145
TaskUs
TASK
$506M
-26,592
Closed -$314K
TBI
2146
Trueblue
TBI
$234M
-44,005
Closed -$200K
TBPH icon
2147
Theravance Biopharma
TBPH
$874M
-58,379
Closed -$1.09M
TDW icon
2148
Tidewater
TDW
$3.91B
-4,943
Closed -$250K
TELA icon
2149
TELA Bio
TELA
$30.9M
-73,811
Closed -$87K
TERN
2150
DELISTED
Terns Pharmaceuticals
TERN
-13,268
Closed -$536K

Similar funds

GSA Capital Partners's Q1 2026 Portfolio in Review

As of Q1 2026, GSA Capital Partners held 2,259 positions worth $1.61B, up 39% from $1.16B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

GSA Capital Partners deployed $533M of net new capital in Q1 2026, opening 642 new positions and adding to 549 existing holdings. Its largest new stake was Vanguard Intermediate-Term Corporate Bond ETF: 389,989 shares worth $32.3M.

By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 13% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was NVIDIA, an estimated $4.12M trimmed.

  • GSA Capital Partners's largest Q1 2026 buy was Vanguard Intermediate-Term Corporate Bond ETF: 389,989 shares worth $32.3M.
  • GSA Capital Partners added most to Vanguard Short-Term Corporate Bond ETF in Q1 2026, an estimated $39.8M increase.
  • GSA Capital Partners's biggest Q1 2026 reduction was NVIDIA, cutting an estimated $4.12M.
  • GSA Capital Partners fully exited EOG Resources in Q1 2026, selling an estimated $4.13M.
  • GSA Capital Partners's ten largest holdings make up 12% of its $1.61B portfolio in Q1 2026.
  • GSA Capital Partners opened 642 new positions and closed 595 in Q1 2026.
  • GSA Capital Partners's portfolio value rose 39% quarter-over-quarter to $1.61B.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.